A newly identified vulnerability in a cancer-driving protein could pave the way for a different approach to treating prostate cancer. Researchers at the University of Michigan have identified a potential way to target a protein that helps drive prostate cancer but has long been considered beyond the reach of drugs. Their experimental compound, PBITE-1, interfered […]
Fox Style News Syndicate. Sourced from broadcast reporting: Read Full Source Coverage.